blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1844788

EP1844788 - HER-2/neu multi-peptide vaccine [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.05.2011
Database last updated on 02.11.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU		published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Bio Life Science Forschungs- und Entwicklungsges.m.b.H.
Kohlmarkt 3
1010 Wien / AT
[2007/42]
Inventor(s)01 / Zielinski, Christoph
Dr.-Heinrich-Maier-Strasse 20
1180 Vienna / AT
02 / Schreiner, Otto
Petersbachgasse 12b
2380 Perchtoldsdorf / AT
03 / Pehamberger, Hubert
Schwingulgasse 20
1230 Vienna / AT
04 / Breiteneder, Heimo
Kandlgasse 9/23
1070 Vienna / AT
05 / Wiedermann, Ursula
Rohrbacherstrasse 5A
1130 Vienna / AT
 [2007/42]
Representative(s)Kador & Partner Part mbB
Corneliusstraße 15
80469 München / DE
[N/P]
Former [2007/42]Kador & Partner
Corneliusstrasse 15
80469 München / DE
Application number, filing date06007834.213.04.2006
[2007/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1844788
Date:17.10.2007
Language:EN
[2007/42]
Type: B1 Patent specification 
No.:EP1844788
Date:14.07.2010
Language:EN
[2010/28]
Search report(s)(Supplementary) European search report - dispatched on:EP11.12.2006
ClassificationIPC:A61K39/00, A61K39/385, A61K39/39, A61P35/00
[2007/42]
CPC:
A61P35/00 (EP); A61K39/001106 (EP,US); A61K2039/545 (EP,US);
A61K2039/55533 (EP,US); A61K2039/55538 (EP,US); A61K2039/55544 (EP,US);
A61K2039/55594 (EP,US); A61K2039/57 (EP,US); A61K2039/6037 (EP,US);
A61K2039/6081 (EP,US); A61K2039/627 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/42]
TitleGerman:HER-2/neu Multipeptidimpfstoff[2007/42]
English:HER-2/neu multi-peptide vaccine[2007/42]
French:HER-2/neu vaccin à base de multiples peptides[2007/42]
Examination procedure16.04.2008Examination requested  [2008/22]
28.05.2008Despatch of a communication from the examining division (Time limit: M06)
27.11.2008Reply to a communication from the examining division
19.08.2009Despatch of a communication from the examining division (Time limit: M02)
04.09.2009Reply to a communication from the examining division
25.01.2010Communication of intention to grant the patent
28.05.2010Fee for grant paid
28.05.2010Fee for publishing/printing paid
Opposition(s)15.04.2011No opposition filed within time limit [2011/25]
Fees paidRenewal fee
31.03.2008Renewal fee patent year 03
30.04.2009Renewal fee patent year 04
24.02.2010Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipBE14.07.2010
CY14.07.2010
CZ14.07.2010
DK14.07.2010
EE14.07.2010
FI14.07.2010
HU14.07.2010
LT14.07.2010
LV14.07.2010
PL14.07.2010
RO14.07.2010
SE14.07.2010
SI14.07.2010
SK14.07.2010
TR14.07.2010
BG14.10.2010
GR15.10.2010
IS14.11.2010
PT15.11.2010
IE13.04.2011
LU13.04.2011
[2013/45]
Former [2013/44]BE14.07.2010
CY14.07.2010
CZ14.07.2010
DK14.07.2010
EE14.07.2010
FI14.07.2010
LT14.07.2010
LV14.07.2010
PL14.07.2010
RO14.07.2010
SE14.07.2010
SI14.07.2010
SK14.07.2010
TR14.07.2010
BG14.10.2010
GR15.10.2010
IS14.11.2010
PT15.11.2010
IE13.04.2011
LU13.04.2011
Former [2013/25]BE14.07.2010
CY14.07.2010
CZ14.07.2010
DK14.07.2010
EE14.07.2010
FI14.07.2010
LT14.07.2010
LV14.07.2010
PL14.07.2010
RO14.07.2010
SE14.07.2010
SI14.07.2010
SK14.07.2010
BG14.10.2010
GR15.10.2010
IS14.11.2010
PT15.11.2010
IE13.04.2011
LU13.04.2011
Former [2012/20]BE14.07.2010
CY14.07.2010
CZ14.07.2010
DK14.07.2010
EE14.07.2010
FI14.07.2010
LT14.07.2010
LV14.07.2010
PL14.07.2010
RO14.07.2010
SE14.07.2010
SI14.07.2010
SK14.07.2010
BG14.10.2010
GR15.10.2010
IS14.11.2010
PT15.11.2010
IE13.04.2011
Former [2011/29]BE14.07.2010
CY14.07.2010
CZ14.07.2010
DK14.07.2010
EE14.07.2010
FI14.07.2010
LT14.07.2010
LV14.07.2010
PL14.07.2010
RO14.07.2010
SE14.07.2010
SI14.07.2010
SK14.07.2010
BG14.10.2010
GR15.10.2010
IS14.11.2010
PT15.11.2010
Former [2011/23]BE14.07.2010
CY14.07.2010
CZ14.07.2010
DK14.07.2010
EE14.07.2010
FI14.07.2010
LT14.07.2010
LV14.07.2010
PL14.07.2010
SE14.07.2010
SI14.07.2010
SK14.07.2010
BG14.10.2010
GR15.10.2010
IS14.11.2010
PT15.11.2010
Former [2011/19]BE14.07.2010
CY14.07.2010
DK14.07.2010
FI14.07.2010
LT14.07.2010
LV14.07.2010
PL14.07.2010
SE14.07.2010
SI14.07.2010
BG14.10.2010
GR15.10.2010
IS14.11.2010
PT15.11.2010
Former [2011/16]BE14.07.2010
CY14.07.2010
FI14.07.2010
LT14.07.2010
LV14.07.2010
PL14.07.2010
SE14.07.2010
SI14.07.2010
BG14.10.2010
GR15.10.2010
IS14.11.2010
PT15.11.2010
Former [2011/13]CY14.07.2010
FI14.07.2010
LT14.07.2010
PL14.07.2010
SI14.07.2010
BG14.10.2010
IS14.11.2010
PT15.11.2010
Former [2011/12]FI14.07.2010
LT14.07.2010
PL14.07.2010
SI14.07.2010
BG14.10.2010
PT15.11.2010
Former [2011/08]LT14.07.2010
Documents cited:Search[X]JPH05117165  (UEDA MASAKAZU, et al);
 [X]WO0108636  (UNIV OHIO STATE [US]);
 [XD]EP1236740  (BIO LIFE SCIENCE FORSCHUNGS & ENTWICKLUNGSGESELLSCHAFT MBH [AT]);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.